中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
2010年
9期
553-557
,共5页
邓春艳%李富荣%王新根%齐晖%任莉莉%周汉新%邓绍平
鄧春豔%李富榮%王新根%齊暉%任莉莉%週漢新%鄧紹平
산춘염%리부영%왕신근%제휘%임리리%주한신%산소평
间质干细胞%胰岛移植%免疫耐受
間質榦細胞%胰島移植%免疫耐受
간질간세포%이도이식%면역내수
Islets of langerhans transplantation%Mesenchymal stem cells%Immune tolerance
目的 探讨同种异基因小鼠骨髓间充质干细胞(MSC)与胰岛联合移植对胰岛移植物的免疫调节作用.方法 将18只糖尿病模型小鼠随机分成3组:(1)糖尿病组,不进行任何移植;(2)胰岛移植组,在无菌操作下将10μl纯化后的200个胰岛移植于受者的左肾包膜下;(3)胰岛+MSC移植组,除与胰岛移植组进行相同的移植外,还在胰岛移植前3、2、0d经受者尾静脉分别注射1×106个MSC.移植后,连续监测非空腹血糖至第30 d;第14和28 d对移植部位的左肾进行组织病理学观察;采集外周血进行免疫荧光染色,流式细胞术分析TH1/TH2、Tc1/Tc2细胞的比值、初始和记忆T淋巴细胞的变化、以及骨髓来源的树突状细胞(DC)成熟度和功能的变化.结果 与胰岛移植组比较,胰岛+MSC移植组血糖明显降低,移植部位炎症细胞浸润明显减轻,移植物的存活时间延长;TH1和Tc1细胞明显下降,TH2和Tc2细胞升高,TH1/TH2和Tc1/Tc2细胞比值显著下降;初始T淋巴细胞和记忆T淋巴细胞下调;DC成熟度降低,分泌白细胞介素12(IL-12)的能力下降.结论 MSC与胰岛联合移植可通过对T淋巴细胞和树突状细胞的免疫调节作用,减轻胰岛移植物的排斥反应,从而延长移植胰岛的存活时间.
目的 探討同種異基因小鼠骨髓間充質榦細胞(MSC)與胰島聯閤移植對胰島移植物的免疫調節作用.方法 將18隻糖尿病模型小鼠隨機分成3組:(1)糖尿病組,不進行任何移植;(2)胰島移植組,在無菌操作下將10μl純化後的200箇胰島移植于受者的左腎包膜下;(3)胰島+MSC移植組,除與胰島移植組進行相同的移植外,還在胰島移植前3、2、0d經受者尾靜脈分彆註射1×106箇MSC.移植後,連續鑑測非空腹血糖至第30 d;第14和28 d對移植部位的左腎進行組織病理學觀察;採集外週血進行免疫熒光染色,流式細胞術分析TH1/TH2、Tc1/Tc2細胞的比值、初始和記憶T淋巴細胞的變化、以及骨髓來源的樹突狀細胞(DC)成熟度和功能的變化.結果 與胰島移植組比較,胰島+MSC移植組血糖明顯降低,移植部位炎癥細胞浸潤明顯減輕,移植物的存活時間延長;TH1和Tc1細胞明顯下降,TH2和Tc2細胞升高,TH1/TH2和Tc1/Tc2細胞比值顯著下降;初始T淋巴細胞和記憶T淋巴細胞下調;DC成熟度降低,分泌白細胞介素12(IL-12)的能力下降.結論 MSC與胰島聯閤移植可通過對T淋巴細胞和樹突狀細胞的免疫調節作用,減輕胰島移植物的排斥反應,從而延長移植胰島的存活時間.
목적 탐토동충이기인소서골수간충질간세포(MSC)여이도연합이식대이도이식물적면역조절작용.방법 장18지당뇨병모형소서수궤분성3조:(1)당뇨병조,불진행임하이식;(2)이도이식조,재무균조작하장10μl순화후적200개이도이식우수자적좌신포막하;(3)이도+MSC이식조,제여이도이식조진행상동적이식외,환재이도이식전3、2、0d경수자미정맥분별주사1×106개MSC.이식후,련속감측비공복혈당지제30 d;제14화28 d대이식부위적좌신진행조직병이학관찰;채집외주혈진행면역형광염색,류식세포술분석TH1/TH2、Tc1/Tc2세포적비치、초시화기억T림파세포적변화、이급골수래원적수돌상세포(DC)성숙도화공능적변화.결과 여이도이식조비교,이도+MSC이식조혈당명현강저,이식부위염증세포침윤명현감경,이식물적존활시간연장;TH1화Tc1세포명현하강,TH2화Tc2세포승고,TH1/TH2화Tc1/Tc2세포비치현저하강;초시T림파세포화기억T림파세포하조;DC성숙도강저,분비백세포개소12(IL-12)적능력하강.결론 MSC여이도연합이식가통과대T림파세포화수돌상세포적면역조절작용,감경이도이식물적배척반응,종이연장이식이도적존활시간.
Objective To investigate the immune regulatory effects of allogeneic bone marrowderived mesenchyrnal stem cells (MSCs) co-transplanted with islets. Methods The 18 diabetic mice were randomly divided into 3 groups: Diabetic group, without any transplantation; Islet transplantation group, in a sterile operation, with 10 μl purified islets (about 200 islets)transplantation to the left renal subcapsule of recipients; Islet + MSCs transplantation group, in addition to transplantation as the former group, 1 × 106 MSCs were given to the recipients via tail vein on 3, 2 and 0 days before islet transplantation. Blood glucose in recipient mice was monitored for 30consecutive days after transplantation. Pathological characteristics of left kidney were analyzed on the day 14 and 28 after transplantation. Th1/Th2, Tc1/Tc2, naive and memory T cells from peripheral blood and bone marrow-derived dendritic cells (DCs) were analyzed by multi-color flow cytometry.Results As compared with the islet transplantation group, blood glucose was significantly reduced,inflammatory cell infiltration decreased in the place of transplantation, graft survival prolonged, the number of Th1 and Tc1 cells was obviously reduced, the number of Th2 and Tc2 cells increased, the ratio of Th1/Th2 and Tc1/Tc2 cells was significantly decreased, the naive and memory T cells were significantly inhibited, the maturity of DCs and the secretion of interleukin-12 decreased in the islet transplantation group. Conclusion Through the immunomodulation on T-cell and DCs function,MSCs can alleviate graft verse host disease and prolong allograft survival.